HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

[Peritoneal mesothelioma: the importance of ultrastructural study. A report of 2 cases and a review of the Spanish literature].

Abstract
Two cases of peritoneal mesothelioma (PM), with ultrastructural study, of females who lived in a rural area without asbestos exposition history are described and the Spanish literature reviewed. We highlight the association with severe autoimmune hemolytic anemia, due to the presence of cold agglutinins, in one patient without relationship to drugs or concomitant diseases. We focus on the need for thorough and multiple biopsies through laparoscopy to avoid false negative. We believe that there are no totally specific morphological data on mesothelioma, which means that the initial study is based on optical microscopy performed with hematoxylin-eosin and PAS-diastase stain using the electronic microscopy to confirm the diagnosis.
AuthorsV M Gutiérrez-Rave Pecero, R Luque Márquez, E Andrada Becerra, R Creagh Cerquera, E Suárez García, E Pujol de la Llave
JournalAnales de medicina interna (Madrid, Spain : 1984) (An Med Interna) Vol. 7 Issue 5 Pg. 261-4 (May 1990) ISSN: 0212-7199 [Print] SPAIN
Vernacular TitleMesotelioma peritoneal: importancia del estudio ultraestructural. Aportación de dos casos y revisión de la literatura española.
PMID2102724 (Publication Type: Case Reports, English Abstract, Journal Article, Review)
Topics
  • Aged
  • Anemia, Hemolytic, Autoimmune (diagnosis, etiology, pathology)
  • Biopsy
  • Female
  • Humans
  • Mesothelioma (complications, diagnosis, ultrastructure)
  • Middle Aged
  • Peritoneal Neoplasms (complications, diagnosis, ultrastructure)
  • Peritoneum (pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: